TASIGNA

Capsule, hard, 150mg
RxActive license

Active substance (INN)

nilotinib

Pharmaceutical form

Pharmaceutical formCapsule, hard
Strength150mg
PackagingUkupno 112 kapsula tvrdih u blisteru (28x4) u kartonskoj kutiji
ManufacturerNovartis Pharmaceutical Manufacturing LLC, Slovenia
Therapeutic groupAntineoplastic and immunomodulating agents (L01EA03)
Marketing authorization holder"NOVARTIS PHARMA SERVICES AG" DIO STRANOG DRUŠTVA PODGORICA
Authorization dateOctober 8, 2024

Analogs in Montenegro

6

Other medicines with the same active substance

NILMATRx
Capsule, hard, 150mgGalenika a.d. Beograd
NILMATRx
Capsule, hard, 200mgGalenika a.d. Beograd
NILOTINIB STADARx
Capsule, hard, 50mgStada Arzneimittel AG
NILOTINIB STADARx
Capsule, hard, 150mgStada Arzneimittel AG
NILOTINIB STADARx
Capsule, hard, 200mgStada Arzneimittel AG
TASIGNARestricted
Capsule, hard, 200mgNovartis Pharma Stein AG
Source: CInMED register